DE69033614D1 - Kondensierte Purinderivate - Google Patents
Kondensierte PurinderivateInfo
- Publication number
- DE69033614D1 DE69033614D1 DE69033614T DE69033614T DE69033614D1 DE 69033614 D1 DE69033614 D1 DE 69033614D1 DE 69033614 T DE69033614 T DE 69033614T DE 69033614 T DE69033614 T DE 69033614T DE 69033614 D1 DE69033614 D1 DE 69033614D1
- Authority
- DE
- Germany
- Prior art keywords
- alkyl
- represents hydrogen
- lower alkyl
- purine derivatives
- condensed purine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229940083251 peripheral vasodilators purine derivative Drugs 0.000 title abstract 2
- 125000000561 purinyl group Chemical class N1=C(N=C2N=CNC2=C1)* 0.000 title abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 2
- 208000001953 Hypotension Diseases 0.000 abstract 1
- 239000000043 antiallergic agent Substances 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000004342 dicyclopropylmethyl group Chemical group [H]C1([H])C([H])([H])C1([H])C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 239000002934 diuretic Substances 0.000 abstract 1
- 229940030606 diuretics Drugs 0.000 abstract 1
- 208000021822 hypotensive Diseases 0.000 abstract 1
- 230000001077 hypotensive effect Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 239000003223 protective agent Substances 0.000 abstract 1
- 125000005504 styryl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27340389 | 1989-10-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69033614D1 true DE69033614D1 (de) | 2000-09-28 |
DE69033614T2 DE69033614T2 (de) | 2001-04-19 |
Family
ID=17527409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69033614T Expired - Fee Related DE69033614T2 (de) | 1989-10-20 | 1990-10-19 | Kondensierte Purinderivate |
Country Status (7)
Country | Link |
---|---|
US (1) | US5270316A (de) |
EP (1) | EP0423805B1 (de) |
JP (1) | JP2988711B2 (de) |
AT (1) | ATE195739T1 (de) |
CA (1) | CA2028235C (de) |
DE (1) | DE69033614T2 (de) |
ES (1) | ES2152207T3 (de) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5338743A (en) * | 1988-06-06 | 1994-08-16 | Fujisawa Pharmaceutical Co., Ltd. | New use of the adenosine antagonist |
NZ238609A (en) * | 1990-06-21 | 1993-12-23 | Schering Corp | Polycyclic guanine derivatives; preparation, pharmaceutical compositions, |
CA2094270C (en) * | 1990-10-18 | 1997-01-21 | Fumio Suzuki | Xanthine derivatives |
US5756735A (en) * | 1990-10-18 | 1998-05-26 | Kyowa Hakko Kogyo Co., Ltd. | Xanthine derivatives |
US5442062A (en) * | 1991-10-24 | 1995-08-15 | The Upjohn Company | Imidazole derivatives and pharmaceutical compositions containing the same |
CA2112031A1 (en) * | 1992-12-24 | 1994-06-25 | Fumio Suzuki | Xanthine derivatives |
AU681875B2 (en) * | 1993-02-26 | 1997-09-11 | Schering Corporation | 2-benzyl-polycyclic guanine derivatives and process for preparing them |
AU6781194A (en) * | 1993-05-03 | 1994-11-21 | United States Of America, Represented By The Secretary, Department Of Health And Human Services, The | 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists |
CA2206287C (en) | 1994-12-13 | 2001-03-20 | Mark Chasin | Aryl thioxanthines |
US5824683A (en) * | 1995-11-28 | 1998-10-20 | Schering Corporation | 2'- 4'-halo- 1,1'-biphenyl!-4-yl!methyl!-5'-methyl-spiro cyclopentane-1,7' (8'H)- 3H! imidazo 2,1-b!purin!-4' (5'H)-ones |
US6294541B1 (en) | 1996-06-06 | 2001-09-25 | Euro-Celtique S.A. | Purine derivatives having phosphodiesterase IV inhibition activity |
WO1998015555A1 (fr) * | 1996-10-07 | 1998-04-16 | Kyowa Hakko Kogyo Co., Ltd. | Derives de purine fondue |
JP2002508378A (ja) | 1997-12-12 | 2002-03-19 | ユーロ−セルティーク,エス.エイ. | 3−置換アデニンおよびイミダゾピリジンの製造方法 |
WO2000001388A1 (fr) * | 1998-07-02 | 2000-01-13 | Kyowa Hakko Kogyo Co., Ltd. | Medicaments antidiabetiques |
US6319928B1 (en) * | 1998-11-30 | 2001-11-20 | Euro-Celtique, S.A. | Purine derivatives having phosphodiesterase IV inhibition activity |
HUP0200938A2 (en) | 1999-04-02 | 2002-10-28 | Euro Celtique Sa | Purine derivatives having phosphodiesterase iv inhibition activity and medicaments containing them |
BR0015545A (pt) * | 1999-11-12 | 2002-08-06 | Biogen Inc | Policicloalquilpurinas como antagonistas dos receptores para adenosina |
PT1230241E (pt) * | 1999-11-12 | 2007-05-31 | Biogen Idec Inc | Antagonistas do receptor de adenosina e métodos de fabrico e uso dos mesmos |
DE60018216T2 (de) * | 1999-12-24 | 2006-02-16 | Kyowa Hakko Kogyo Co., Ltd. | Kondensierte purinderivate |
US7087589B2 (en) * | 2000-01-14 | 2006-08-08 | The United States Of America As Represented By The Department Of Health And Human Services | Methanocarba cycloakyl nucleoside analogues |
KR20040011439A (ko) * | 2000-12-01 | 2004-02-05 | 바이오겐, 인코포레이티드 | A1 아데노신 수용체 길항제로서 축합된 퓨린 유도체 |
US6423844B1 (en) | 2001-06-06 | 2002-07-23 | The United States Of America As Represented By The Secretary Of The Navy | Process for making 1,2,4-triazolo[4,3-a][1,3,5]triazine-3,5,7-triamine |
CN1777608A (zh) * | 2003-04-25 | 2006-05-24 | 协和发酵工业株式会社 | 稠合嘧啶衍生物 |
US20070196340A1 (en) * | 2003-05-06 | 2007-08-23 | Aldo Ammendola | Modulation of Pathogenicity |
US8962629B2 (en) | 2008-06-10 | 2015-02-24 | Abbvie Inc. | Tricyclic compounds |
HUE033099T2 (en) | 2009-12-01 | 2017-11-28 | Abbvie Inc | New tricyclic compounds |
EP2506713A4 (de) | 2009-12-01 | 2014-09-03 | Abbvie Inc | Neue trizyklische verbindungen |
WO2011068978A1 (en) | 2009-12-02 | 2011-06-09 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methanocarba adenosine derivatives and dendrimer conjugates thereof |
JP2017527606A (ja) * | 2014-09-18 | 2017-09-21 | サノビオン ファーマシューティカルズ インクSunovion Pharmaceuticals Inc. | 三環系誘導体 |
CN116284011A (zh) | 2015-10-16 | 2023-06-23 | 艾伯维公司 | 制备咪唑并[1,2-a]吡咯并[2,3-e]吡嗪类化合物及其固态形式的方法 |
US10550126B2 (en) | 2015-10-16 | 2020-02-04 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-A]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
US11773106B2 (en) | 2015-10-16 | 2023-10-03 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
US11524964B2 (en) | 2015-10-16 | 2022-12-13 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
US11512092B2 (en) | 2015-10-16 | 2022-11-29 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
US11365198B2 (en) | 2015-10-16 | 2022-06-21 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
CN114106000B (zh) * | 2021-12-15 | 2023-11-24 | 中国科学院新疆理化技术研究所 | 一种咪唑并[4,5-d]嘧啶酮三环类衍生物及抗肿瘤用途 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1095906A (en) * | 1977-02-14 | 1981-02-17 | Davis L. Temple, Jr. | Heterocyclopyrimidines, compositions and therapeutic process |
BE863525A (fr) * | 1977-02-14 | 1978-07-31 | Bristol Myers Co | Heterocyclopyrimidines |
SE7810946L (sv) | 1978-10-20 | 1980-04-21 | Draco Ab | Metod att behandla kronisk obstruktiv luftvegssjukdom |
US4870181A (en) | 1985-02-04 | 1989-09-26 | A. H. Robins Company, Incorporated | Process for the preparation of 2-alkoxy-N-(1-azabicyclo[2.2.2])octan-3-yl)aminobenzamides |
US4710503A (en) | 1985-02-07 | 1987-12-01 | Euroceltique S.A. | 6-thioxanthine derivatives |
AU623755B2 (en) * | 1989-03-29 | 1992-05-21 | Merrell Pharmaceuticals Inc. | Selective adenosine receptor compounds |
US5064947A (en) * | 1989-03-29 | 1991-11-12 | Merrell Dow Pharmaceuticals Inc. | Selective adenosine reseptor compounds |
US5086176A (en) * | 1989-03-29 | 1992-02-04 | Merrell Dow Pharmaceuticals Inc. | Tricyclic fused adenine derivatives |
ATE145908T1 (de) * | 1989-09-14 | 1996-12-15 | Kyowa Hakko Kogyo Kk | 5-triazolo(3,4-i)purinderivate |
-
1990
- 1990-10-19 EP EP90120056A patent/EP0423805B1/de not_active Expired - Lifetime
- 1990-10-19 US US07/599,758 patent/US5270316A/en not_active Expired - Fee Related
- 1990-10-19 JP JP28157890A patent/JP2988711B2/ja not_active Expired - Fee Related
- 1990-10-19 ES ES90120056T patent/ES2152207T3/es not_active Expired - Lifetime
- 1990-10-19 DE DE69033614T patent/DE69033614T2/de not_active Expired - Fee Related
- 1990-10-19 CA CA002028235A patent/CA2028235C/en not_active Expired - Fee Related
- 1990-10-19 AT AT90120056T patent/ATE195739T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ES2152207T3 (es) | 2001-02-01 |
EP0423805A2 (de) | 1991-04-24 |
ATE195739T1 (de) | 2000-09-15 |
DE69033614T2 (de) | 2001-04-19 |
US5270316A (en) | 1993-12-14 |
CA2028235A1 (en) | 1991-04-21 |
JP2988711B2 (ja) | 1999-12-13 |
CA2028235C (en) | 1997-01-21 |
EP0423805A3 (en) | 1992-01-02 |
JPH03204880A (ja) | 1991-09-06 |
EP0423805B1 (de) | 2000-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69033614D1 (de) | Kondensierte Purinderivate | |
NO302755B1 (no) | Morfinan-derivater | |
ES2091212T3 (es) | Compuestos de xantina. | |
DE69027235D1 (de) | Xanthinderivate | |
DK232989A (da) | Antiviralt praeparat | |
NO934536D0 (no) | Fenoksy- og fenoksyalkyl-pepiridiner som antivirale midler | |
ATE45354T1 (de) | Chinoloncarbonsaeurederivate. | |
ES2150613T3 (es) | Compuestos benzo-condensados de acepinona y piperidinona, utiles como inhibidores de ace y nep. | |
DE69001722D1 (de) | Entzuendungshemmende und/oder antiallergische zusammensetzung, die glutathionderivate enthaelt. | |
NO921159L (no) | Tiazolidinon- og oksazolidinonderivater, fremgangsmaate til fremstilling derav, samt anvendelse av derivatene som vasodilatorer | |
DK0417790T3 (da) | S-triazolo(3,4-i)purin-derivater | |
ATE55057T1 (de) | Zentralwirkende muskelrelaxante. | |
DK0654473T3 (da) | Cyclopropanderivater og antivirale midler med indhold deraf | |
ATE105565T1 (de) | Pradimicinderivate. | |
ES2109962T3 (es) | Derivados de la naftiridina condensados. | |
FI883507A (fi) | Naftotiazepinderivat och deras framstaellning. | |
ES527115A0 (es) | Derivados de benzo (f) quinolina | |
FR2598914B1 (fr) | Composition prophylactique et curative pour l'arteriosclerose |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |